Research and Markets (http://www.researchandmarkets.com/research/4ff2rq/fallopian_tube)
has announced the addition of the "Fallopian
Tube Cancer - Pipeline Review, H1 2014" report to their
This report provides comprehensive information on the therapeutic
development for Fallopian Tube Cancer, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Fallopian Tube Cancer and special features on late-stage and
The report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources.
Drug profiles/records featured in thereport undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
For more information visit http://www.researchandmarkets.com/research/4ff2rq/fallopian_tube
[ Back To NFVZone's Homepage ]